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As with all members of the WHO Classification of
Tumours series, this book is well presented and repre-
sents exceedingly good value for money. In general the
quality of production is good, with the photography of high
to very high quality with good illustrations and colour
balance. Plentiful micro and macroscopic pictures are pre-
sented, the latter being particularly helpful in the sections
dealing with gynaecological lesions. Unfortunately, in
some cases the illustrations are poor, for example fig
1.105c is out of focus or too small, fig 184, which is
stated to show ADH, is of too low power to serve any
useful purpose.
The text offers a well-organised and comprehensive review
of breast and gynaecological tumours. In particular, this
volume deserves a lot of praise for its synthesis of taxon-
omy with molecular pathology and probably gives to date
the best ready reckoner for molecular and cytogenetic
alterations in breast and gynaecological cancer within a
pathology textbook. This synthesis could have been taken
further, for example in the breast section no reference to
the work relating HER2 amplification with epidermotro-
pism and Paget’s disease is given [1,2]. Some of the
gynaecological text also deserves particular praise; the
section on inherited tumour syndromes gives a masterly
overview of a complicated subject.
Like all such books there was clear evidence that this text
had been written by a committee and in several places the
opportunity for reaching a consensus view on some impor-
tant issues was lost. Most notably, with regards to micro-
invasion, many different definitions were given, and one
would have thought that the WHO were just the body that
would provide some unification with regards to this sort of
contentious area. On the other hand I am glad to see that
a cautious approach to the premature concept of lobular
intraepithelial neoplasia (LIN) and ductal intralobular neo-
plasia (DIN) was adopted. The concept is, in theory,
attractive but until the various and probably multiple lines
of breast cancer evolution are more clearly identified, this
concept must remain in cold storage.
In other areas apparent consensus in the book is not
matched by reality; the section on mucinous cystic lesions
associated with pseudomyxoma peritonei rather oversim-
plifies what remains a still contentious area of pathology.
The pattern of referencing in the text was to a certain
extent patchy and didn’t include some of the original
descriptions of many lesions, for example the co-incidence
of mammary hamartoma and pseudoangiomatous stromal
hyperplasia [3]. These oversights no doubt relate to the
idiosyncratic knowledge of the literature, which many spe-
cialist histopathologists have. Occasionally the selectivity
is misleading; in the section on lobular carcinoma it is
stated that loss of E-cadherin occurs and that this loss is
associated with poor prognosis. The implication given was
that this related to lobular carcinoma but the references
related to breast cancers in general. Even that view has
been challenged, because loss of E-cadherin in ductal
carcinomas is not independent of grade [4].
With regards to particular diagnostic aspects of the text,
there are perhaps several areas that might have been
further explored, although I appreciate that space is of a
premium in a book such as this. For example, ductal
adenoma of the breast is dealt with very briefly but in fact
these lesions have a hugely diverse morphology that may
lead to diagnostic difficulty.
Despite some criticism then, this book represents a job
well done and provides an extremely good, though at
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